Cellectar Biosciences, Inc.

NasdaqCM:CLRB Stock Report

Market Cap: US$22.5m

Cellectar Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CLRB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 May 26BuyUS$24,998James CarusoIndividual8,680US$2.88
07 May 26BuyUS$24,998Jarrod LongcorIndividual8,680US$2.88
12 Dec 25SellUS$732John NeisIndividual198US$3.70

Insider Trading Volume

Insider Buying: CLRB insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CLRB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders172,3452.16%
Institutions1,382,34417.3%
General Public6,437,12380.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 179.7%.

Top Shareholders

Top 25 shareholders own 19.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.99%
Janus Henderson Group plc
798,382US$2.2m0%no data
2.46%
Stonepine Capital Management LLC
196,930US$553.4k0%0.24%
1.56%
Brendan O’Neil
125,000US$351.2k0%no data
1.25%
Bleichroeder LP
100,000US$281.0k-50%0.05%
1.02%
Vanguard Capital Management, LLC
81,884US$230.1k0%no data
0.8%
Intracoastal Capital LLC
63,872US$179.5k0%1.91%
0.66%
Geode Capital Management, LLC
52,778US$148.3k84.3%no data
0.26%
Jarrod Longcor
20,451US$57.5k60.2%no data
0.25%
James Caruso
20,318US$57.1k74.6%no data
0.24%
Sequoia Financial Advisors, LLC
18,850US$53.0k-25.6%no data
0.21%
Vanguard Fiduciary Trust Company
16,573US$46.6k0%no data
0.17%
Warberg Asset Management LLC
13,900US$39.1k0%0.08%
0.13%
Riverview Capital Advisers, LLC
10,384US$29.2k0%0.01%
0.12%
UBS Asset Management AG
9,647US$27.1k271%no data
0.11%
Dimensional Fund Advisors LP
8,431US$23.7k0%no data
0.08%
Chad Kolean
6,418US$18.0k0%no data
0.059%
BlackRock, Inc.
4,745US$13.3k0%no data
0.032%
ADAR1 Capital Management, LLC
2,540US$7.1k0%no data
0.014%
Nantahala Capital Management, LLC
1,109US$3.1k0%no data
0.0099%
Tower Research Capital Europe Limited
793US$2.2k-56.7%no data
0.007%
Vanguard Global Advisers, LLC
563US$1.6k0%no data
0.0064%
Morgan Stanley
510US$1.4k0%no data
0.0053%
Spearhead Insurance Solutions Idf, Llc
422US$1.2k0%0.01%
0.001%
Douglas Swirsky
83US$233.60%no data
0.00081%
Frederick Driscoll
65US$181.90%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 07:54
End of Day Share Price 2026/07/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cellectar Biosciences, Inc. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Keith MarkeyGriffin Securities
Kevin DeGeeterLadenburg Thalmann & Company